Clinical Trial Update: A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the Phase 1 safety and tolerability results of PCI-24781 in cancer patients. The study, sponsored by Pharmacyclics LLC, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Leukemia
• Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• PCI-24781 (PCI-24781)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Lymphoma, Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED